Skip to main content
MindWalk Holdings Corp. logo

MindWalk Holdings Corp. — Investor Relations & Filings

Ticker · HYFT ISIN · CA45257F2008 US Professional, scientific and technical activities
Open in API
Filings indexed 256 across all filing types
Latest filing 2021-11-30 Regulatory Filings
Country US United States of America
Listing US HYFT

About MindWalk Holdings Corp.

https://www.ipatherapeutics.com/

MindWalk Holdings Corp. is a Bio-Native AI company that focuses on transforming drug discovery and development. The company operates a biointelligence ecosystem that integrates artificial intelligence, multi-omics data, and advanced laboratory research to make complex biology computable and actionable. This unified platform is designed to accelerate the discovery and development of biologics, including therapeutic antibodies, diagnostics, vaccines, and peptide therapeutics, from target identification through to the clinical stage. Its capabilities are powered by proprietary technologies such as the patented HYFT® technology and the LensAI™ platform, which are adaptable to specific targets, modalities, and program priorities.

Recent filings

Filing Released Lang Actions
IMMUNOPRECISE ANTIBODIES LTD. 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer submitted to the SEC under the Securities Exchange Act of 1934. It includes a press release as an exhibit but does not contain detailed financial statements or substantive financial data. The document length is short (1397 characters), and it primarily serves as a regulatory filing to report current information rather than a full financial report or earnings release. According to the rules, Form 6-K filings are best classified under Regulatory Filings (RNS) as they are miscellaneous regulatory announcements that do not fit other specific categories.
2021-11-30 English
IMMUNOPRECISE ANTIBODIES LTD. 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer submitted to the SEC under the Securities Exchange Act of 1934. It includes a press release as an exhibit but does not contain detailed financial statements or substantive financial data. The document length is short (1397 characters), and it primarily serves as a regulatory filing to report current information rather than a full financial report or earnings release. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other specific categories.
2021-11-24 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign issuer, ImmunoPrecise Antibodies Ltd., with the SEC. It includes an exhibit index referencing a Notice of Annual General Meeting of Shareholders and a Form of Proxy for the AGM. The document itself is short (1496 characters) and primarily serves as a cover report to submit these exhibits. There is no substantive financial data or detailed report content within this text. According to the 'Menu vs Meal' rule, such a filing that references attached reports or notices but does not contain the reports themselves should be classified as a Regulatory Filing (RNS).
2021-11-12 English
IMMUNOPRECISE ANTIBODIES LTD. 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, ImmunoPrecise Antibodies Ltd., pursuant to SEC rules. It is a report submitted under the Securities Exchange Act of 1934, specifically a 6-K form, which is used for current reports by foreign private issuers. The document includes a press release as an exhibit but does not contain detailed financial statements or comprehensive report content. The length is short (1397 characters), and it primarily serves as a notification or announcement rather than a full report. According to the classification rules, such filings are best categorized under Regulatory Filings (RNS) as they do not fit into other specific report categories and are not full annual or interim reports.
2021-11-10 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign issuer, ImmunoPrecise Antibodies Ltd., with the SEC. It includes an exhibit index listing a Notice of Change of Auditor and letters from former and successor auditors. The document is short (1564 characters) and primarily serves as an announcement of auditor change and related correspondence. It does not contain detailed financial statements, audit opinions, or substantive financial data. Therefore, it is not an Audit Report itself but rather a regulatory announcement related to audit matters. Given the nature and length, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-10-29 English
IMMUNOPRECISE ANTIBODIES LTD. FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer submitted to the SEC under the Securities Exchange Act of 1934. It includes a press release as an exhibit but does not contain detailed financial statements or substantive financial data. The document length is short (1399 characters), and it primarily serves as a regulatory filing to report information periodically or as required. It does not represent an annual report, earnings release, or other detailed financial report. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories.
2021-10-14 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.